CPHI 2023 Interview: Going with the flow in drug substance manufacturing 30-Oct-2023 By Jonathan Smith Continuous flow manufacturing is taking off in the production of active pharmaceutical ingredients (APIs).
Sterling Pharma kicks off hydroxychloroquine production 19-May-2020 By Jenni Spinner The British CDMO will manufacture the API for the potential COVID-19 treatment, and partner Accord Healthcare will manufacture the finished product.
Chinese government steps in to ensure supply of essential medicine 29-Apr-2019 By Ben Hargreaves China’s NHC announces that it will monitor the market for essential medicines and act to increase the supply of drug substances and regulate pricing.